Lidia Jiménez-García
  • Unidad de Terapias Farmacológicas, Área de Genética Humana, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III, Spain
Research fields
  • Immunology
Personal information

Education

M.S. in Pharmacy, University of Granada, 2012

Current position

Ph.D. student of Pharmacology Therapies Unit, Research institute for Rare diseases (IIER), Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid

Publications

  1. Mota, A., Jimenez-Garcia, L., Herranz, S., de Las Heras, B. and Hortelano, S. (2015). alpha-Hispanolol sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis via death receptor up-regulation. Toxicol Appl Pharmacol 286(3): 168-177.
  2. Jimenez-Garcia, L., Herranz, S., Luque, A. and Hortelano, S. (2015). Critical role of p38 MAPK in IL-4-induced alternative activation of peritoneal macrophages. Eur J Immunol 45(1): 273-286.
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.